CSL Ltd (ASX: CSL) and ResMed Inc. (ASX: RMD) have fallen to 52-week lows. Here's why I think patient investors should look ...

CSL is one of three Tier 1 plasma therapy companies that benefit from an oligopoly in a highly consolidated market. All the players are vertically integrated, as plasma sourcing is a key constraint in ...

The global biotechnology company will brief analysts on its latest downgrade on Monday morning after a horror year for the business.

Why did CSL (ASX: CSL) shares sink in May? A downgrade, weaker growth outlook and major impairments hit sentiment.

CSL ( (AU:CSL)) has shared an announcement. CSL Limited has provided an updated daily notification on its ongoing on-market share buy-back of ordinary fully paid shares, originally launched in August ...

Bollinger Bands Trading Strategies: How to Read Volatility, Identify Market Regimes, and Trade with a Statistical Edge CSL’s 15.96% drop pressured the ASX 200 after FY26 guidance was cut due to a US ...

Caretaker CSL chief executive Gordon Naylor has urged investors to keep the faith despite a $6.9bn impairment that challenges its claim to being one of Australia’s leading blue chip companies.

CSL's yield now rivals a big four bank... The post Historic: Here's why CSL shares are looking very interesting right now ...